- Home
- SCPH vs MRCC Comparison
SCPH vs MRCC Comparison
Compare SCPH & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- MRCC
- Stock Information
- Founded
- SCPH 2013
- MRCC 2011
- Country
- SCPH United States
- MRCC United States
- Employees
- SCPH N/A
- MRCC N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- MRCC Investment Managers
- Sector
- SCPH Health Care
- MRCC Finance
- Exchange
- SCPH Nasdaq
- MRCC Nasdaq
- Market Cap
- SCPH 173.6M
- MRCC 176.4M
- IPO Year
- SCPH 2017
- MRCC 2012
- Fundamental
- Price
- SCPH $2.44
- MRCC $6.38
- Analyst Decision
- SCPH Strong Buy
- MRCC Hold
- Analyst Count
- SCPH 3
- MRCC 1
- Target Price
- SCPH $14.00
- MRCC $8.00
- AVG Volume (30 Days)
- SCPH 237.4K
- MRCC 68.7K
- Earning Date
- SCPH 05-16-2025
- MRCC 05-07-2025
- Dividend Yield
- SCPH N/A
- MRCC 15.67%
- EPS Growth
- SCPH N/A
- MRCC 3301.50
- EPS
- SCPH N/A
- MRCC 0.32
- Revenue
- SCPH $36,332,000.00
- MRCC $56,983,000.00
- Revenue This Year
- SCPH $109.32
- MRCC N/A
- Revenue Next Year
- SCPH $76.95
- MRCC N/A
- P/E Ratio
- SCPH N/A
- MRCC $19.63
- Revenue Growth
- SCPH 167.28
- MRCC N/A
- 52 Week Low
- SCPH $1.94
- MRCC $6.44
- 52 Week High
- SCPH $5.65
- MRCC $8.85
- Technical
- Relative Strength Index (RSI)
- SCPH 46.18
- MRCC 31.99
- Support Level
- SCPH $2.24
- MRCC $6.80
- Resistance Level
- SCPH $2.64
- MRCC $7.14
- Average True Range (ATR)
- SCPH 0.17
- MRCC 0.25
- MACD
- SCPH 0.01
- MRCC -0.02
- Stochastic Oscillator
- SCPH 38.46
- MRCC 6.38
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About MRCC Monroe Capital Corporation
Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.